CXCL12 and neoplasm: Studies have further indicated that elevated expression levels of both CXCL12 and CXCR4 correlate with unfavorable prognosis in lymph node-positive cases, as well as with tumor-stroma ratio (TSR) and lymphocytic infiltration at the invasive front (LIR) [91,92].